I am interested in setting up some guidelines for determination of 7aad viability for CD34 analysis. These guidelines will be for users not familiar with doing this type of analysis. Any suggestions will be appreciated. Thanks, Jim Kurtz James W. Kurtz Research Associate Jerome Holland Laboratory for Biomedical Sciences American Red Cross B/CT R&D 15601 Crabbs Branch Way Rockville, MD. 20855 Ph# 301-738-0669 Fx# 301-738-0704 Email: jkurtz@USA.Redcross.org
This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:26:06 EST